Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8373f3013dca535a8f1ad5458725f6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
filingDate |
2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc03a07422ba79268060d899fb4d106c |
publicationDate |
2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DE-10240064-A1 |
titleOfInvention |
CXCR4 receptor antagonists |
abstract |
The present invention relates to the use of a chemokine receptor antagonist as a ligand for the CXCR4 receptor for apoptosis-inducing treatment and / or for preventing metastasis of cancer cells in a patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010006755-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2149567-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102137849-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010006755-A3 |
priorityDate |
2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |